FAQs
IHDMA is a professional body focused on advancing the
science and practice of hyperbaric and diving medicine in
India through research, education, collaboration, and public
awareness.
HBOT is a medical treatment where a patient breathes 100%
oxygen in a pressurized chamber. It is used for a wide range
of conditions including non-healing wounds, carbon monoxide
poisoning, decompression sickness, and radiation injuries.
Membership is open to healthcare professionals, researchers,
technicians, and institutions involved in hyperbaric
medicine, diving medicine, or related disciplines.
Yes. IHDMA follows globally accepted guidelines while
working toward developing national protocols suited for
Indian healthcare settings.
Please refer to the IHDMA Chamber Directory for an updated
list of participating and recognized facilities across
India.
IHDMA encourages adherence to international safety standards
(e.g., UHMS, ECHM) and supports local adaptation through
policy development and training.
Yes. IHDMA collaborates with accredited institutions to
conduct workshops, certification programs, and CME
activities focused on hyperbaric and diving medicine.
FUHM is awarded to qualified professionals who meet
educational, clinical, and examination criteria. Please
visit the FUHM Guidelines page for eligibility and
application details.
Yes. IHDMA is actively involved in creating India-specific
practice guidelines, which are regularly reviewed and
updated based on clinical evidence and expert consensus.
HBOT is used to treat diabetic foot ulcers, radiation tissue
damage, non-healing wounds, decompression illness, carbon
monoxide poisoning, gas gangrene, crush injuries, and more.
You can apply through the official IHDMA website by
submitting an application form along with required documents
and fees.
Members gain access to educational resources, professional
networks, research initiatives, certification programs, and
updated clinical guidelines.
Yes. Hospitals, research institutions, and clinics can apply
for institutional membership to access collaborative
projects and training.
Yes. Emergency HBOT is available at selected centers for
acute conditions like gas embolism, carbon monoxide
poisoning, and decompression sickness.
Side effects are rare but can include barotrauma, sinus
pain, oxygen toxicity, and temporary visual changes.
Treatments are conducted under medical supervision.
The number varies depending on the condition. Acute
conditions may require a few sessions, while chronic issues
may need 20–40 sessions.
Facilities must have certified pressure chambers, oxygen
systems, emergency protocols, and trained personnel as per
safety standards.
Only trained professionals such as certified hyperbaric
physicians, nurses, and chamber operators are authorized to
run HBOT sessions.
Monoplace chambers are suitable for many conditions, but
some complex cases may require multiplace chambers for
intensive monitoring.
Members and centers can contribute by submitting clinical
data, participating in working groups, or initiating
collaborative research under IHDMA guidance.
IHDMA supports publication of research in peer-reviewed
journals and is planning to launch its own publication
platform in the near future.
Yes. Researchers may request access to de-identified
registry data for academic purposes. Approval is subject to
IHDMA's ethics and steering committee review.